Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-20

Clinical Trial Update: Cognitive Rehabilitation in Sickle Cell Disease [NA]

View source ↗

Summary

The document reports that the clinical trial examining cognitive rehabilitation for individuals with sickle cell disease and cognitive impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: Sickle Cell Disease, Cognitive Impairment | NA | Status: COMPLETED